Journal of Medicinal Chemistry · 2009 · 139 citations · 37 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsCannabinoid PharmacologyLigand BindingPotency OptimizationReceptor PharmacologyStructure-activity Relationship AnalysisCannabinoid AgonistsCannabinoid Receptor PharmacologyCannabinoid Structure-activity RelationshipsIndole Derivatives
Several 3-acylindoles with high affinity for the CB(2) cannabinoid receptor and selectivity over the CB(1) receptor have been prepared. A variety of 3-acyl substituents were investigated, and the tetramethylcyclopropyl group was found to lead to high affinity CB(2) agonists (5, 16). Substitution at the N1-indole position was then examined. A series of aminoalkylindoles was prepared and several substituted aminoethyl derivatives were active (23-27, 5) at the CB(2) receptor. A study of N1 nonaromatic side chain variants provided potent agonists at the CB(2) receptor (16, 35-41, 44-47, 49-54, and 57-58). Several polar side chains (alcohols, oxazolidinone) were well-tolerated for CB(2) receptor activity (41, 50), while others (amide, acid) led to weaker or inactive compounds (55 and 56). N1 aromatic side chains also afforded several high affinity CB(2) receptor agonists (61, 63, 65, and 69) but were generally less potent in an in vitro CB(2) functional assay than were nonaromatic side chain analogues.
37
Molecular characterization of a peripheral receptor for cannabinoids
Sean Munro, Kerrie L. Thomas, Muna Abu-Shaar · Nature · 1993 · 5.1K citations
Cristina Benito, Estefanía Núñez, Rosa M. Tolón et al. · Journal of Neuroscience · 2003 · 618 citations · Full text
Cannabinoids control spasticity and tremor in a multiple sclerosis model
David Baker, Gareth Pryce, J. Ludovic Croxford et al. · Nature · 2000 · 531 citations
Medicine, Neurology, Neuroscience +14